Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Ventricular tachycardia].

C Brunckhorst1, F Duru, C Scharf

  • 1Universitätsspital Zürich. cbrunckhorst@earthlink.net

Praxis
|July 19, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence for the Collective Nature of Radial Flow in Pb+Pb Collisions with the ATLAS Detector.

Physical review letters·2026
Same author

Evidence for the Dimuon Decay of the Higgs Boson in pp Collisions with the ATLAS Detector.

Physical review letters·2025
Same author

Evidence for Longitudinally Polarized W Bosons in the Electroweak Production of Same-Sign W Boson Pairs in Association with Two Jets in pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

Physical review letters·2025
Same author

Observation of tt[over ¯] Production in Pb+Pb Collisions at sqrt[s_{NN}]=5.02  TeV with the ATLAS Detector.

Physical review letters·2025
Same author

Search for Dark Matter Produced in Association with a Dark Higgs Boson in the bb[over ¯] Final State Using pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

Physical review letters·2025
Same author

Search for Magnetic Monopole Pair Production in Ultraperipheral Pb+Pb Collisions at sqrt[s_{NN}]=5.36  TeV with the ATLAS Detector at the LHC.

Physical review letters·2025
Same journal

Praxis·2026
Same journal

[What do Swiss doctors think about cardiovascular risk factors and guidelines?]

Praxis·2026
Same journal

[Laser interstitial thermotherapy (LITT): a minimally invasive neurosurgical treatment option for brain tumours and radiation necrosis].

Praxis·2026
Same journal

[Persistent back pain after lifting trauma. From the trivial to the rare case].

Praxis·2026
Same journal

[A patient with dizziness and gait instability - a diagnostic challenge].

Praxis·2026
Same journal

[Meningoencephalitis caused by listeria monocytogenes].

Praxis·2026
See all related articles

Understanding triggers for ventricular tachycardias (VT) is key for effective treatment. Specialized care is crucial for complex cases like sudden cardiac death survivors and cardiomyopathies.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Arrhythmology

Context:

  • Ventricular tachycardias (VT) arise from structural/functional conditions triggered by various factors.
  • Accurate diagnosis of VT mechanisms is essential for selecting optimal therapeutic strategies.
  • Management options include antiarrhythmic drugs, ICD implantation, catheter ablation, or combination therapy.

Purpose:

  • To emphasize the importance of understanding VT triggers and underlying conditions.
  • To highlight the necessity of specialized diagnostic approaches and tailored management for complex VT cases.
  • To identify patient groups requiring referral to specialized electrophysiology centers.

Summary:

  • Effective management of ventricular tachycardias (VT) hinges on understanding the interplay between underlying conditions and triggers.

Related Experiment Videos

  • Treatment strategies encompass pharmacotherapy, device implantation (ICD), catheter ablation, and multimodal approaches.
  • Patient prognosis is influenced by the etiology of VT, its specific mechanism, and the chosen therapeutic intervention.

    • Impact:

    • Facilitates appropriate treatment selection for ventricular tachycardias.
    • Improves patient outcomes by enabling specialized care for complex arrhythmias.
    • Guides referral pathways for patients with high-risk cardiac conditions and arrhythmias.